Cluster Headache
75
11
12
35
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.3%
10 terminated out of 75 trials
77.8%
-8.8% vs benchmark
9%
7 trials in Phase 3/4
23%
8 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 35 completed trials
Clinical Trials (75)
Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache
Italian Trigeminal Autonomic Cephalalgias Assessment Study
High- vs Standard-Dose Intravenous Magnesium for Acute Headache
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
Nurse Intervention Trial
The Will Erwin Headache Research Center - Cluster Headache Study
Pain Biomarker Study
Cluster Headache Treatment Survey
Cluster Headache Treatment With Rimegepant
Atrioventricular Block and Cluster Headache (SEVA)
Repeated GON Injections in CCH
nVNS for the Prevention and Treatment of Primary Headache
China Headache and Vertigo Registry Study
Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache
Efficacy of Light Therapy in Treatment of Chronic Cluster Headache
A Research Study to Examine Cutaneous Allodynia and Cluster Headache
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache
Treatment of Chronic Cluster Headache with TENS and ONS
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache